Ledger.Open graph →
SEC Form D · filed December 11, 2017

EpiVax Oncology, Inc

Offering
$2.0M
Sold
$50K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PROVIDENCE, RI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Gad Berdugo · Providence, RIExecAnne De Groot · Providence, RIExec · DirectorWilliam Martin · Providence, RIExec · DirectorG. R. Zage · ALPHARETTA, GAExec · DirectorMartin A. Klingel, Jr · Charlottesville, VAExec · DirectorWilliam J. Gordon, Jr · Charlottesville, VAExecJames H. Whitcomb · Atlanta, GAExec · DirectorMaya Capital Ventures GP I, LLC · SAO PAULO, GuernseyExecRakesh Malhotra · Wakefield, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗